| Literature DB >> 35601584 |
Abstract
While it goes without saying that ethically sound practices are imperative for high-quality educational scholarship, institutional ethics guidance is often unclear about how to treat educational scholarship generally, and quality improvement/assurance studies and the scholarship of teaching and learning, specifically. Amongst health profession education researchers, including those in pharmacy, this lack of clarity has led to confusion regarding existing ethics governance and ambivalence regarding ethics requirements. Drawing on the experiences of one pharmacy school in western Canada, this commentary describes an ethics vetting guide developed explicitly to address current uncertainty about ethics requirements for pharmacy education scholarship. Clarifying the problem, describing the guide, and exploring what was learned along the way provide a basis for re-centering ethics in the development of scholarly projects and decision-making regarding formal ethics review. The importance of instilling ethical intelligence, delineating research from quality improvement/assurance work, and addressing current gaps in ethics oversight and governance of educational scholarship are among key lessons learned during guide development along with suggestions for new institutional ethics guidance directly targeting educational scholarship to supplement current national guidelines. © Individual authors.Entities:
Keywords: educational scholarship; ethics review; ethics vetting guide; quality assurance/improvement; scholarship of teaching and learning
Year: 2021 PMID: 35601584 PMCID: PMC9120004 DOI: 10.24926/iip.v12i3.3919
Source DB: PubMed Journal: Innov Pharm ISSN: 2155-0417
Overview of the ethics vetting guide
|
|
|
| I | Situates the importance of educational scholarship in the Faculty’s research mandate and the associated historical challenges of formal BREB review decision-making at UBC. Significant effort is dedicated to clarifying key confounders in decision-making related to the TCPS 2 classifications of research and QA/QI work. Aspects of study design, such as locus of attention, data sources, expectations of faculty and students, theoretical frameworks, generalizability, and dissemination priorities, provide additional criteria for delineation. |
| II | Reminds pharmacy education researchers about the importance of ethical conduct of research involving humans regardless of project classification. An associated appendix provides accepted standards of ethical practice for all education-related studies involving humans. Principles described include consent, informing students, confidentiality and anonymity, vulnerability, and beneficence. |
| III | Describes a four-step process that engages pharmacy education researchers in thinking critically about ethically-sound research, and implications for their studies. In addition to getting started activities, a questionnaire helps classify projects as research or QA/QI studies according to TCPS 2 definitions and make decisions about whether or not formal ethics review is required. Further consultation and a focus on dissemination practices completes the process. |
| IV | Provides the supporting appendix. Along with the key principles of ethical research conduct mentioned in Section II, examples of how the guide has been applied are included. Research projects requiring formal BREB review and ethics-exempt QA/QI studies completed by pharmacy education researchers in our Faculty are highlighted. Entries include project titles and abstracts, project team members, questionnaire answers with final decisions, and specific language acknowledging REB decisions (regarding approvals and exemptions) for dissemination purposes in presentations, journal article submission requirements, and publications. |
Figure 1.The four-step ethics decision-making process.
Ethics classification questionnaire
| Questions[ | Answers |
|---|---|
| 1. Does the project/study fit the TCPS’ definition of “research” or “quality assurance/improvement”? Explain. | Research or QA/QI?; Justification |
| 2. Will any of the concepts of consent, informing students, confidentiality, vulnerability, and beneficence be compromised at any time during the project? | Yes/No |
| 3. Is there uncertainty of possible risk to any participant through experiencing either physical or psychological distress or discomfort? | Yes/No |
| 4. Is the project design and methodology rigorous enough to statistically support generalizations beyond the particular context and/or population that will participate in the project? | Yes/No |
| 5. Is the project funded by (or being submitted to) a grant/award competition from a funding agency that requires research ethics review? | Yes/No |
| 6. Does the project involve “randomization” to contrast interventions to participants or other systematic sampling techniques to divide participants into different groups? | Yes/No |
| 7. Does the project involve a comparison of interventions or processes and “control” settings or groups either to test a new intervention or to assess the effectiveness of a process change? | Yes/No |
Decision point: If you are clear about your answer to question 1 and answered “No” to questions 2-7 then your project is likely a quality assurance/improvement project/study and may not require formal BREB review. If you are unsure about your answer to question 1 and/or answered “Yes” to any of questions 2-7 then your project may require a formal BREB application and review.